ROBERT E. BECK, M.D.; ARTHUR A. HOBBS JR., M.D.
Within the last decade radioactive iodine has become the therapeutic agent of first importance in the treatment of hyperthyroid disease. It is commonly accepted as the treatment of choice in Graves's disease,1, 2 and has been used in the treatment of other types of hyperthyroidism.
There continues to be disagreement as to the advisability of its use for younger people, in certain types of goiter, and with reference to exophthalmos.3, 6 Dosage is still somewhat empiric, though related mathematically to the estimated size of the thyroid and the tracer dose uptake.7, 12 It is our purpose to relate briefly
BECK RE, HOBBS AA. OBSERVATIONS IN THE TREATMENT OF HYPERTHYROIDISM WITH I131*. Ann Intern Med. 1957;47:241–247. doi: https://doi.org/10.7326/0003-4819-47-2-241
Download citation file:
Published: Ann Intern Med. 1957;47(2):241-247.
Endocrine and Metabolism, Thyroid Disorders.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use